Content Video
Spotlight on Tech Transfer Bottlenecks: A Quick Look at Hidden Risks
[0:09] Your tech transfer package is complete.
[0:12] Six months later, you're still chasing deviations from PPQ, rerunning experiments, and watching a six-month plan quietly stretch toward 18 months.
[0:21] Here's the twist. The problem often isn't the science — it's how scientific knowledge is captured, shared, and used.
[0:29] In this video, we'll uncover where tech transfer bottlenecks hide, and why managing QbD through static tools increases risk, rework, and delays.
[0:38] QbD should be your backbone for tech transfer, connecting QTPP, risks, and control strategy.
[0:44] Yet often that backbone lives in static documents.
[0:47] Decisions are hard to trace, versions drift, and when experts leave, their rationale goes with them.
[0:53] The result? Failed engineering or validation batches, repeated experiments, and teams piecing the story together from scattered files without a shared knowledge base.
[1:04] Tech transfer isn't a one-time handoff.
[1:06] It happens across the lifecycle. When it's treated as: “Here’s the package — good luck!”
[1:11] Misreads and mix-ups follow.
[1:13] Paper and “paper-on-glass” workflows only deliver a snapshot — not a shared understanding of the process.
[1:20] Even when the tech transfer plan is solid, operations can still slow everything down.
[1:24] Systems don't connect, problems surface too late, and timelines quietly drift again and again.
[1:31] Now imagine this scenario: QbD frameworks built as connected workflows — not documents.
[1:37] A shared digital backbone for critical attributes, risks, and decisions, and teams using the same knowledge base.
[1:44] Then knowledge management stops being a bottleneck and starts driving right-first-time tech transfers.
[1:50] If these feel familiar, your tech transfer process is carrying too many risks.
[1:55] See how a digital, knowledge-centric approach can help you reduce it.
Summary
Tech transfer delays often come from how knowledge is captured and shared, not the science. Static documents and fragmented QbD outputs make decisions hard to trace.
Version drift, one-time handoffs, and siloed systems slow feedback and raise the chance of rework, deviations, and failed engineering or validation batches.
Key takeaways
• Static QbD in PDFs and spreadsheets makes CPP and risk rationale hard to find, so teams repeat work and lose context when SMEs move on.
• Treating tech transfer as a one-time package creates misinterpretation between sending and receiving sites and makes a single version of the truth hard to maintain.
• Disconnected MES, LIMS, ERP, and QMS data delays issue detection, stretching timelines and increasing the risk of deviations and batch failure.
Who is this for
• Tech transfer leads and CMC program managers
• Process development and scale-up teams
• MS&T teams supporting site readiness and PPQ
• QA and deviation investigation teams
• QC and analytical method transfer leads
• CDMO sponsor oversight and external manufacturing teams
• Regulatory CMC teams preparing submissions and launch readiness
Relevant entities and links
• ICH Q8(R2) Pharmaceutical Development (QbD framework): https://database.ich.org/sites/default/files/Q8_R2_Guideline.pdf
• ICH Q9(R1) Quality Risk Management: https://database.ich.org/sites/default/files/ICH_Q9-R1_Document_Step2_Guideline_2021_1118.pdf
• ICH Q10 Pharmaceutical Quality System: https://database.ich.org/sites/default/files/Q10%20Guideline.pdf
• WHO TRS 961, Annex 7: Transfer of technology in pharmaceutical manufacturing (PDF): https://www.who.int/docs/default-source/medicines/norms-and-standards/guidelines/production/trs961-annex7-transfer-technology-pharmaceutical-manufacturing.pdf?sfvrsn=2e302838_0
• ISPE Good Practice Guide: Technology Transfer (3rd Edition): https://ispe.org/publications/guidance-documents/good-practice-guide-technology-transfer-3rd-edition
